CLINICAL_TRIALS
research
· 2025-10-30
Clinical Trial Update: Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Summary
A Phase 2 trial evaluating oral digoxin in people with amyotrophic lateral sclerosis is currently active but not recruiting. The study is sponsored by Massachus…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 2 | Status: ACTIVE_NOT_RECRUITING